Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunome (IMNM) Other Working Capital Changes: 2023-2025

Historic Other Working Capital Changes for Immunome (IMNM) over the last 2 years, with Jun 2025 value amounting to -$4.0 million.

  • Immunome's Other Working Capital Changes fell 336.41% to -$4.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$10.6 million, marking a year-over-year increase of 15.83%. This contributed to the annual value of $390,488 for FY2024, which is 601.43% up from last year.
  • Per Immunome's latest filing, its Other Working Capital Changes stood at -$4.0 million for Q2 2025, which was down 3,712.89% from $111,130 recorded in Q1 2025.
  • Immunome's 5-year Other Working Capital Changes high stood at $111,130 for Q1 2025, and its period low was -$4.3 million during Q2 2023.
  • Over the past 3 years, Immunome's median Other Working Capital Changes value was -$2.8 million (recorded in 2024), while the average stood at -$2.2 million.
  • Per our database at Business Quant, Immunome's Other Working Capital Changes soared by 11,694.39% in 2024 and then slumped by 336.41% in 2025.
  • Immunome's Other Working Capital Changes (Quarterly) stood at -$3.8 million in 2023, then climbed by 28.44% to -$2.7 million in 2024, then crashed by 336.41% to -$4.0 million in 2025.
  • Its Other Working Capital Changes stands at -$4.0 million for Q2 2025, versus $111,130 for Q1 2025 and -$2.7 million for Q4 2024.